Sector pending / Orthopedic, Prosthetic, and Surgical Appliances and SuppliesUpdated 2026-05-10 22:07 UTC

FRA/OWX stock hub

FRA/OWX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/OWXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/OWX

In the news

Latest news · FRA/OWX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23

P25 n/aP50 n/aP75 n/a

Trailing P/E20.8

P25 n/aP50 n/aP75 n/a

ROE27.2

P25 n/aP50 n/aP75 n/a

ROIC27.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/OWX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

CHF

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	2,000
Employees Change	-644%
Employees Change Percent	-24.36
Enterprise value	EUR 4.3B
Exchange	Frankfurt Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Last refreshed	2026-05-10
Market cap	EUR 4.3B
Price	EUR 324
Price currency	EUR
Rev Per Employee	420,895.94x
Sic	3842
Symbol	fra/OWX
Website	https://www.ypsomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.82%
EV Earnings	20.63x
EV/EBIT	16.34x
EV/EBITDA	13.37x
EV/FCF	-184.44x
EV/Sales	4.97x
FCF yield	-0.54%
Forward P/E	22.99x
P/B ratio	4.99x
P/E ratio	20.77x
P/S ratio	5.12x
PE Ratio10 Y	104.42x
PE Ratio3 Y	53.15x
PE Ratio5 Y	54.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.42%
EBITDA Margin	37.19%
Gross margin	39.29%
Gross Profit	EUR 330.8M
Gross Profit Growth	5.95%
Gross Profit Growth Q	13.1%
Gross Profit Growth3 Y	12.12%
Gross Profit Growth5 Y	17.09%
Net Income	EUR 207.4M
Net Income Growth	160.8%
Net Income Growth Q	326.67%
Net Income Growth3 Y	35.28%
Net Income Growth5 Y	30.49%
Pretax Margin	27.34%
Profit Margin	24.63%
Profit Per Employee	EUR 103,680
ROA	12.53
Roa5y	3.69
ROCE	25.03
ROE	27.15
Roe5y	8.98
ROIC	27.65
Roic5y	6.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.8%
Div CAGR10	9.8%
Div CAGR3	21.86%
Div CAGR5	17.25%
EPS Growth	160.7
EPS Growth Q	326.7
EPS Growth3 Y	35.28
EPS Growth5 Y	30.05
OCF Growth	35.1%
OCF Growth Q	94.9%
OCF Growth10 Y	14.55%
OCF Growth3 Y	9.05%
OCF Growth5 Y	10.32%
Revenue Growth	27.63x
Revenue Growth Q	11.94x
Revenue Growth3 Y	12.82x
Revenue Growth5 Y	9.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.66
Assets	EUR 1.3B
Cash	EUR 38.8M
Current Assets	EUR 403.8M
Current Liabilities	EUR 274.7M
Debt	EUR 10.7M
Debt EBITDA	EUR 0.03
Debt Equity	EUR 0.01
Debt FCF	EUR -0.46
Equity	EUR 862.8M
Interest Coverage	43.27
Liabilities	EUR 429.1M
Long Term Assets	EUR 888.1M
Long Term Liabilities	EUR 154.5M
Net Cash	EUR 28.1M
Net Cash By Market Cap	EUR 0.65
Net Debt EBITDA	EUR -0.09
Net Debt Equity	EUR -0.03
Tangible Book Value	EUR 696.9M
Tangible Book Value Per Share	EUR 51.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	6.34
Net Working Capital	EUR 98.3M
Quick ratio	0.75
Working Capital	EUR 126.5M
Working Capital Turnover	EUR -31.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	13.26%
Dividend Growth Years	3%
Dividend per share	EUR 2.35
Dividend Years	18
Dividend Yield	0.79%
Ex Div Date	2025-07-04
Last Dividend	EUR 2.35
Payout Frequency	Annual
Payout Ratio	15.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.79%
200-day SMA	351.3
50-day SMA	306.1
50-day SMA vs 200-day SMA	50under200
All Time High	469.5
All Time High Change	-30.91%
All Time High Date	2025-07-18
All Time Low	287
All Time Low Change	13.03%
All Time Low Date	2026-03-02
ATR	4.83
Ch YTD	-6.65
High	324.4
High52	469.5
High52 Date	2025-07-18
High52ch	-30.91%
Low	324.4
Low52	287
Low52 Date	2026-03-02
Low52ch	13.03%
Ma50ch	5.97%
Price vs 200-day SMA	-7.66%
RSI	62.58
RSI Monthly	0
RSI Weekly	47.77
Sharpe ratio	-0.32x
Sortino ratio	-0.29
Total Return	0.8%
Tr YTD	-6.65
Tr1m	7.7%
Tr1w	9.67%
Tr3m	3.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 256.1M
Operating Income Growth	94.64
Operating Income Growth Q	229.6
Operating Income Growth3 Y	40.59
Operating Income Growth5 Y	40.8
Operating margin	30.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,007,431%
Net Borrowing	-234,649,149.6
Shares Insiders	70.56%
Shares Institutions	10.83%
Shares Qo Q	0%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -23.2M
Average Volume	5.8x
Bv Per Share	63.23
CAPEX	EUR -249.5M
Ch1m	7.7
Ch1w	9.67
Ch1y	-13.26
Ch3m	3.31
Ch6m	-0.8
Change	1.95%
Change From Open	0
Close	318.2
Days Gap	1.95
Depreciation Amortization	58,187,532.1
Earnings Date	2026-05-20
EBIT	EUR 256.1M
EBITDA	EUR 313.1M
EPS	EUR 15.19
F Score	7
FCF	EUR -23.2M
FCF EV Yield	-0.54x
Financing CF	-263,644,572
Fiscal Year End	March
Founded	1,984
Graham Number	151.14457
Graham Upside	-53.41
Income Tax	EUR 22.7M
Investing CF	20,617,541
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-09-30
Lynch Fair Value	EUR 391
Lynch Upside	20.38
Ma150	329.8
Ma150ch	-1.64%
Ma20	309.1
Ma20ch	4.94%
Net CF	-17,115,904
Next Earnings Date	2026-05-20
Open	324.4
P OCF Ratio	19.03
Payment Date	2025-07-08
Ppne	670,679,656.2
Price Date	2026-05-08
Price EBITDA	EUR 13.76
Ptbv Ratio	6.18
Relative Volume	10.53x
Revenue	841,791,884x
Tax By Revenue	2.7x
Tax Rate	9.89%
Tr6m	-0.8%
Z Score	9.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/OWX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$2.35 annual per share

Payout ratio

+15.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.2%

3 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2025-07-04

Performance

FRA/OWX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/OWX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.8%

Share of float held by funds and institutions

Insider ownership

+70.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

FRA/OWX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.6

Neutral momentum band

Price vs 200-day MA

-7.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/OWX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/OWX stock rating?

fra/OWX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/OWX analysis?

The full report lives at /stocks/fra/OWX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/OWX?

The latest report frames fra/OWX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/OWX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.